In addition, compared with the AD group, the levels of alarmin TSLP and pro-inflammatory cytokine IL-1β in the serum of mice in the 15 mg/kg AZF treatment group were significantly reduced (Figure 3D,E). This evidence concerns the gene IL1B and Alzheimer disease.